Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $91,959.57 +1.48%
Ethereum $3,322.16 +6.01%
BNB $885.93 -0.28%
Optimism $0.33 +3.25%
Arbitrum $0.22 +0.29%
Solana $137.11 +2.95%
Polygon $0.22 +2.77%
Cosmos $2.25 +0.21%
Avalanche $14.20 +4.05%

Bitcoin $91,959.57 +1.48%
Ethereum $3,322.16 +6.01%
BNB $885.93 -0.28%
Optimism $0.33 +3.25%
Arbitrum $0.22 +0.29%
Solana $137.11 +2.95%
Polygon $0.22 +2.77%
Cosmos $2.25 +0.21%
Avalanche $14.20 +4.05%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B